Skip to main content

Table 2 Relative frequency of glioma molecular subgroups according to the 2016 WHO classification

From: Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation

Molecular Subgroups

Number of samples

% Gliomas

GBM, IDH mutant

11

2.5 (11/444)

GBM, IDH-wildtype

245

55.2 (245/444)

Astrocytoma, IDH-mutant

55

12.4 (55/444)

Astrocytoma, IDH-wildtype

43

9.7 (43/444)

IDH mutant and 1p/19q codeleted

49

11.0 (49/444)

NOS

41

9.2 (41/444)

Total

444

100 (444/444)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us